Russia to ensure faster registration of innovative drugs in domestic market

Russia plans to take additional measures to speed registration of new drugs in the domestic market – in a move, that will allow the country to avoid a potential shortage caused by sanctions and their consequences, reports The Pharma Letter’s local correspondent.

As part of these, the Russian Parliament (State Duma) plans to prepare a new bill in the fall session that will simplify the registration of new drugs in the country. These plans also involve the reduction of bureaucratic procedures, the transition to electronic document management.

Will include vaccines and rare disease therapies